miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1

Xin Wang(Jiangsu University), Longhua Chen(San’an Optoelectronics (China))

Oncology Reports

April 18, 2018

10.3892/or.2018.6379

Cited by 35

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

|The Lancet Oncology|2021|436

A Comparison of Whole-Genome Shotgun-Derived Mouse Chromosome 16 and the Human Genome

|Science|2002|370

The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing

|Journal of Translational Medicine|2021|91

miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44

|Theranostics|2019|86

LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation

|Nature Communications|2023|67